Landmark genetics partnership to probe causes of cancer and dementia Page summary: Oxford Nanopore’s breakthrough genetic sequencing tech to analyse 50,000 samples from UK Biobank, to create a world-first ‘epigenetic map’. Change made: First published. Time updated: 7:00am, 27 November 2024 First patients benefit from cutting-edge UK scanner to transform drug discovery and diagnose serious illnesses earlier Page summary: New…
Ben KempDecember 5, 2024

